Clinical Trials
4 trialsNCT02144623 2017-03-03
PREVAIL
Lund University Hospital
Phase EARLY_PHASE1 Completed
NCT01295593 2012-06-07
Low Dose CdA Combined With Valproic Acid (VPA) in Previously Treated B-cell Chronic Lymphocytic Leukemia(B-CLL)
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Phase 1/2 Unknown
NCT00524667 2011-07-20
HDAC Inhibitor Valproic Acid as an Effective Therapy for Chronic Lymphocytic Leukemia
CancerCare Manitoba
Phase 2 Terminated
NCT00810680 2008-12-18
Study of Efficacy and Safety of Valproic Acid in Chronic Lymphocytic Leukemia (CLL)
All India Institute of Medical Sciences
Phase NA Unknown